Will CBD Show Up on a Drug Test?

What the test is actually measuring

A standard workplace drug screen is a two-stage process. Stage one is an immunoassay — fast, cheap, and deliberately broad. If that flags, the sample goes to stage two: a confirmation test on a mass spectrometer that identifies and quantifies one specific molecule, THC-COOH. Not CBD. Not CBG. Not hemp. A single metabolite of delta-9 THC.

Under SAMHSA's Mandatory Guidelines for federal workplace testing, both stages have to clear their thresholds before anything is reported positive:

Oral fluid testing was authorized as a urine alternative for DOT-regulated programs in 2023, so if you're in a safety-sensitive role you may see either. Hair testing, used more in private-sector screening than federal programs, looks back roughly 90 days.

Where the risk actually comes from

Researchers at Johns Hopkins ran the clean version of this question: give people pure CBD, once, and see what the test says. Nothing. Pure CBD capsules and pure CBD vape produced no positive urine screens. Used once, by itself, CBD isn't the problem.

The problem is what daily use of a full-spectrum product does over weeks. In a published four-week study, participants took a full-spectrum hemp extract under the tongue three times a day. Half of them tested positive on a urine screen by the end. The detail that should stop you: the extract in that study contained about 0.02% THC — roughly fifteen times less than federal law permits in a hemp product. A legal 0.3% full-spectrum oil, taken on the same schedule, is not a safer version of that experiment.

This is the mechanism people miss. THC metabolites are fat-soluble and they accumulate. Each daily dose adds to the reservoir before the last one has cleared. A trace amount that would never register from a single dose can climb past 50 ng/mL after a few weeks of consistency — and consistency is exactly what we tell everyone to do with CBD.

The second risk: the label may be wrong

Everything above assumes the bottle contains what the label says. In this category, that's an assumption worth checking. Multiple analyses of retail CBD products — a 2022 Johns Hopkins study and a 2024 labeling-and-contamination analysis among them — have found that most products tested were inaccurately labeled, some by wide margins, and some contained THC that the label never mentioned.

The Department of Transportation says this out loud in its official CBD notice: CBD products are unregulated and may contain more THC than their labels claim. That's the federal government's stated reason for warning safety-sensitive workers off the category entirely.

There is exactly one defense, and it isn't a brand promise. It's a certificate of analysis from an accredited third-party lab, tied to the batch number printed on the bottle in your hand. If a company can't produce one for your batch, the label is a claim, not a measurement.

If you're DOT-regulated, read this part twice

Commercial drivers, pilots, transit and rail workers, pipeline crews — anyone in a DOT safety-sensitive role — get no benefit of the doubt here. The DOT's Office of Drug and Alcohol Policy and Compliance has published its position plainly: CBD use is not a legitimate medical explanation for a laboratory-confirmed marijuana positive. A Medical Review Officer will verify the result as positive even if you only ever used a CBD product, and Part 40 doesn't authorize marijuana use for any reason.

There's no appeal built on good intentions. If your job is DOT-covered, the only defensible position is a THC-free product with a batch COA you've actually read — and plenty of DOT employers would tell you to skip the category altogether. We'd rather say that than sell you a bottle that costs you a CDL.

How long THC stays detectable

These are ranges, not guarantees. Body composition, metabolism, hydration, dose, and the lab's cutoff all move the number:

Note how the windows stretch rather than scale. That's accumulation again — the same reason a daily full-spectrum habit is a different risk profile than a bottle you open twice a month.

What we'd tell a friend

• Tested at work, or might be? Broad spectrum, full stop. Same cannabinoids and terpenes, THC removed. It's the reason we make it.
• Read the COA for your batch, not the brand's greatest hits. You want THC listed as non-detect on the report that matches the number on your bottle.
• Keep the bottle and the batch number. If a result ever gets questioned, the physical product and its lab report are the only documentation worth having.
• Skip gas-station hemp entirely. Delta-8, THCA flower, and unlabeled “hemp” products will fail a screen, and the test can't tell delta-8 from delta-9.
• Tell your doctor and your employer's policy what you're taking. A conversation before a test beats an explanation after one.

One change worth knowing about

Federal law is about to tighten. A provision signed in November 2025 redefines hemp and takes effect November 12, 2026. Among other changes, a finished consumer product will be limited to no more than 0.4 mg of total intoxicating cannabinoids in the container as sold — a per-bottle limit rather than a percentage. That reshapes what a full-spectrum product can legally be.

We're a family business with four products and no interest in the loophole corner of this industry, so we're watching the rule and we'll say plainly what changes for our lineup as it gets closer. Nothing about that changes today's advice: if you're tested, broad spectrum.

FAQ